Racial Disparities in Diagnosis and Prognosis of Nonalcoholic Fatty Liver Disease
Naga Swetha Samji, Peter D. Snell, Ashwani K. Singal, Sanjaya K. Satapathy – 4 September 2020
Naga Swetha Samji, Peter D. Snell, Ashwani K. Singal, Sanjaya K. Satapathy – 4 September 2020
Tooba Tariq, Archita P. Desai – 4 September 2020
Andrew A. Li, Donghee Kim, Aijaz Ahmed – 4 September 2020
Hilda E. Ghadieh, Raghd Abu Helal, Harrison T. Muturi, Daniella D. Issa, Lucia Russo, Simon L. Abdallah, John A. Najjar, Fabian Benencia, Guillermo Vazquez, Wei Li, Sonia M. Najjar – 3 September 2020 – Patients with nonalcoholic fatty liver disease/steatohepatitis (NAFLD/NASH) commonly develop atherosclerosis through a mechanism that is not well delineated. These diseases are associated with steatosis, inflammation, oxidative stress, and fibrosis. The role of insulin resistance in their pathogenesis remains controversial.
Olaf Tyc, Christian Jansen, Robert Schierwagen, Frank Erhard Uschner, Mads Israelsen, Sabine Klein, Cristina Ortiz, Christian P. Strassburg, Stefan Zeuzem, Wenyi Gu, Sandra Torres, Michael Praktiknjo, Stephan Kersting, Melanie Langheinrich, Jacob Nattermann, Florence Servant, Manimozhiyan Arumugam, Aleksander Krag, Benjamin Lelouvier, Tobias J. Weismüller, Jonel Trebicka – 3 September 2020
Heinz Zoller, Sonja Wagner, Benedikt Schaefer – 3 September 2020
3 September 2020
Alcohol-associated liver disease (ALD) is the leading cause of cirrhosis worldwide. Harmful drinking, especially among youth and women, is increasing. A global alliance and discussion about effective public health strategies is needed.
Zhe Li, Xinyuan Lu, Yanfang Liu, Jingjing Zhao, Shengzhe Ma, Haoxiang Yin, Shenglin Huang, Yingjun Zhao, Xianghuo He – 1 September 2020